Oral products with reduced irritation

Abstract

The disclosure provides products configured for oral use, the products including one or more agents adapted to or configured to reduce irritation that may be associated with release of a component from the products. Xylitol, in particular, may be useful as an irritation reducing agent. The disclosure further provides methods of reducing irritation associated with the release of one or more components from an oral composition or product.

1 . An oral composition comprising:
 an active ingredient that is releasable from the oral composition;   a filler; and   at least one irritation reducing agent effective to reduce irritation arising from the release of the active ingredient from the oral composition.   
     
     
         2 . The oral composition of  claim 1 , wherein the active ingredient is selected from the group consisting of a nicotine component, a botanical, a stimulant, an amino acid, a vitamin, a cannabinoid, a cannabimimetic, a terpene, a nutraceutical, and combinations thereof. 
     
     
         3 . The oral composition of  claim 2 , wherein the active ingredient comprises nicotine or caffeine. 
     
     
         4 . The oral composition of  claim 1 , wherein the at least one irritation reducing agent comprises a non-sugar sweetener. 
     
     
         5 . The oral composition of  claim 1 , wherein the at least one irritation reducing agent is selected from the group consisting of xylitol, sorbitol, camphor, clove oil, coco extract, eugenol, vegetable oil, glycerine, and combinations thereof. 
     
     
         6 . The oral composition of  claim 5 , wherein the at least one irritation reducing agent comprises xylitol. 
     
     
         7 . The oral composition of  claim 6 , wherein the oral composition further comprises a non-nutritive sweetener in addition to the xylitol. 
     
     
         8 . The oral composition of  claim 7 , wherein the non-nutritive sweetener comprises one or both of sucralose and aspartame. 
     
     
         9 . The oral composition of  claim 1 , further comprising one or more flavoring agents. 
     
     
         10 . The oral composition of  claim 9 , wherein the one or more flavoring agents comprises a compound having a carbon-carbon double bond, a carbon-oxygen double bond, or both. 
     
     
         11 . The oral composition of  claim 10 , wherein the one or more flavoring agents comprises one or more aldehydes, ketones, esters, terpenes, terpenoids, or a combination thereof. 
     
     
         12 . The oral composition of  claim 10 , wherein the one or more flavoring agents comprises one or more of ethyl vanillin, cinnamaldehyde, sabinene, limonene, gamma-terpinene, beta-farnesene, and citral. 
     
     
         13 . The oral composition of  claim 1 , wherein the filler component is in a particulate form. 
     
     
         14 . The oral composition of  claim 1 , wherein the filler component is a cellulose material or cellulose derivative. 
     
     
         15 . The oral composition of  claim 1 , wherein the filler component is microcrystalline cellulose. 
     
     
         16 . The oral composition of  claim 1 , wherein the product comprises no more than about 10% by weight of a tobacco material, excluding any nicotine component present, based on the total weight of the mixture. 
     
     
         17 . The oral composition of  claim 1 , wherein the active ingredient, the filler component, and the at least one irritation reducing agent are combined as a mixture that is enclosed in a pouch to form a pouched product, the mixture optionally being in a free-flowing particulate form. 
     
     
         18 . The oral composition of  claim 1 , wherein the oral composition further comprises one or more salts, one or more binding agents, one or more humectants, one or more gums, a tobacco material, or combinations thereof. 
     
     
         19 . The oral composition of  claim 1 , wherein the active ingredient is releasable from the oral composition in one or both of the mouth and throat of a consumer. 
     
     
         20 . A method for reducing irritation associated with an active ingredient in an oral product, the method comprising:
 forming a product to include at least one irritation reducing agent, an active ingredient that is releasable in one or both of the mouth and throat of a consumer, and a filler component, wherein the at least one irritation reducing agent is included in an amount effective to reduce irritation in one or both of the mouth and throat of the consumer arising from the release of the active ingredient from the product.   
     
     
         21 .- 24 . (canceled)